Results 261 to 270 of about 195,338 (284)
Some of the next articles are maybe not open access.
Targeting GM-CSF in inflammatory diseases
Nature Reviews Rheumatology, 2015Granulocyte-macrophage colony stimulating factor (GM-CSF) is a growth factor first identified as an inducer of differentiation and proliferation of granulocytes and macrophages derived from haematopoietic progenitor cells. Later studies have shown that GM-CSF is involved in a wide range of biological processes in both innate and adaptive immunity, with
Ian P, Wicks, Andrew W, Roberts
openaire +2 more sources
Immunological Reviews, 2002
Summary: The crafting of genetic and biochemical techniques to identify cancer antigens yielded the unexpected discovery that immune recognition of tumors regularly accompanies cancer development. The failure of the host to suppress tumor formation or attenuate disease progression may thus reflect the limited immunogenicity of nascent tumors.
openaire +2 more sources
Summary: The crafting of genetic and biochemical techniques to identify cancer antigens yielded the unexpected discovery that immune recognition of tumors regularly accompanies cancer development. The failure of the host to suppress tumor formation or attenuate disease progression may thus reflect the limited immunogenicity of nascent tumors.
openaire +2 more sources
Growth factors (Chur, Switzerland), 2005
Granulocyte macrophage-colony stimulating factor (GM-CSF) was originally defined by its ability to generate in vitro granulocyte and macrophage colonies from bone marrow precursor cells. Apart from its physiological role in the control of alveolar macrophage development, it now appears more likely that its major role lies in its ability to govern the ...
John A, Hamilton, Gary P, Anderson
openaire +1 more source
Granulocyte macrophage-colony stimulating factor (GM-CSF) was originally defined by its ability to generate in vitro granulocyte and macrophage colonies from bone marrow precursor cells. Apart from its physiological role in the control of alveolar macrophage development, it now appears more likely that its major role lies in its ability to govern the ...
John A, Hamilton, Gary P, Anderson
openaire +1 more source
Anti-GM-CSF Titer Predicts Response to GM-CSF Therapy in Pulmonary Alveolar Proteinosis
Clinical Immunology, 2002Pulmonary alveolar proteinosis (PAP) is an idiopathic disease characterized by the accumulation of surfactant in the pulmonary airspaces. The development of a PAP-like syndrome in the GM-CSF knockout mouse and resolution of disease by local GM-CSF expression strongly implicates GM-CSF in surfactant homeostasis and disease pathogenesis.
Tracey L, Bonfield +2 more
openaire +2 more sources
Expression of GM-CSF receptor and “in vitro” effects of GM-CSF on human fibroblasts
Life Sciences, 1998In the present study the effects of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) on fibroblast growth and activity have been studied. In this regard the AA have evaluated in primary cultures of human gengival normal fibroblasts (PG1 cells): a)-the expression of GM-CSF receptor (GM-CSFR) (alfa unit) on the cell surface; b)-the in vitro ...
Postiglione, L +6 more
openaire +4 more sources
GM-CSF in inflammation and autoimmunity
Trends in Immunology, 2002Granulocyte macrophage-colony stimulating factor (GM-CSF) is now best viewed as a major regulator governing the functions of granulocyte and macrophage lineage populations at all stages of maturation. There is recent evidence for a key role for GM-CSF in inflammatory and autoimmune diseases, therefore making it worthy of consideration for targetting ...
openaire +2 more sources
Emerging clinical uses for GM-CSF
European Journal of Cancer and Clinical Oncology, 1991variety early in life. Quitting smoking is associated with a dramatic drop in the risks of bladder cancer [7], irrespective of the type of tobacco. In the two studies which considered the effect of quitting separately by type, the relative risk remained well above the level of non-smokers only for smokers of black tobacco.
openaire +2 more sources
International Journal of Antimicrobial Agents, 1998
M, Middleton, N, Thatcher
openaire +2 more sources
M, Middleton, N, Thatcher
openaire +2 more sources

